Plain-English translation of NCT05346536 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new blood test called a 'liquid biopsy' to detect and study aggressive cancer cells that have spread throughout the body in people with metastatic pancreatic cancer. Instead of taking tissue samples from tumors, doctors take a small blood sample and look for special cancer cells floating in the bloodstream. This new approach may help doctors understand your cancer better and choose the best treatment for you.
When pancreatic cancer spreads to other parts of the body, the cancer cells that travel through the blood can be different from the original tumor — they may respond to different treatments or behave differently. This study exists to see if analyzing these traveling cancer cells in a simple blood test can give doctors important information they wouldn't get from traditional biopsies, helping them avoid unnecessary treatments and side effects.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate a blood sample that doctors will analyze to detect and study aggressive cancer cells in your bloodstream. The blood draw is a routine procedure similar to standard blood tests. This study is observational, meaning researchers are studying your blood cells rather than giving you a new medication — they're gathering information to help understand how this blood test can improve pancreatic cancer care.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
France